Roche plant , sein erstes kontinuierliches Glukosemessgerät (CGM) „in den kommenden Wochen“ in Europa auf den Markt zu bringen, sagte Sérgio Moreiras, der internationale Geschäftsleiter des Unternehmens für kontinuierliche Überwachung, am Dienstag.
Im Juli erhielt das Unternehmen für den Accu-Chek Smartguide die CE-Kennzeichnung , die das Gerät für Menschen ab 18 Jahren mit Typ-1- oder Typ-2-Diabetes zulässt. Roche wird das CGM in den Niederlanden, der Schweiz und Deutschland einführen, sagte Moreiras auf der Jahrestagung der European Association for the Study of Diabetes in Madrid.
Manage Consent
Functional Immer aktiv
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.
The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.